
|Articles|October 23, 2012
Updated: FDA Temporarily Removes List Of Hospitals, Providers That Received Products From Mass. Compounder
Advertisement
Just hours after posting it Monday, the Food and Drug Administration removed from its website a list of hospitals and doctors that had received products from the compounding pharmacy now at the center of the fungal meningitis outbreak, saying data may be incorrect.
The agency said it is working to correct the list and will repost once it is completed. Data had been supplied to the agency by the pharmacy, the New England Compounding Center in Massachusetts.
Read the full story:
Source: Kaiser Health News
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
Sarcoma Gene Signature May Predict Who Benefits From Pazopanib
5




